Addition TherapeuticsListed
additiontx.combiotech_life_sciences
Addition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases in large and rare populations, leveraging its…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Addition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases in large and rare populations, leveraging its…
AIMATX is an AI-driven platform focused on intelligent materials discovery, leveraging machine learning to predict material properties and accelerate the research process.
Dextera Biosciences is pioneering a new class of therapeutics—dexabodies—built entirely from D-amino acids to overcome the key limitations of existing drug modalities. Unlike trad…
Works on oral macrocyclic peptide drugs enabled by AI/ML and a trillion molecule display library.
Khemia Metals aims to replace critical metals with earth-abundant alloys to create lighter, cheaper, and more sustainable batteries for a green future.
Montara Therapeutics is a preclinical-stage biopharmaceutical company pursuing novel approaches to develop safer and more efficacious treatments for neurological diseases. Montara…
Radar Therapeutics is pioneering a new treatment modality: precision-expressed mRNA-based therapeutics. The company leverages advances in single-cell transcriptomic data and RNA-e…
PinkDx — The Gyne Cancer Company™ — is transforming the diagnostic journey in gynecologic cancer. We apply scientific discovery and integrate whole-transcriptome sequencing and ma…